Anti-amyloid β antibodies
View Patent ↗The present invention relates to antibody molecules capable of specifically recognizing two regions of the R-A4 peptide, wherein the first region comprises the amino acid sequence AEFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein the second region comprises the amino acid sequence VHHQKLVFFAEDVG as shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules encoding the inventive antibody molecules and vectors and hosts comprising said nucleic acid molecules are disclosed. In addition, the present invention provides for compositions, preferably pharmaceutical or diagnostic compositions, comprising the compounds of the invention as well as for specific uses of the antibody molecules, nucleic acid molecules, vectors or hosts of the invention.
1. An antibody molecule comprising
(a) a variable V L -Region comprising complementary determining regions, L-CDR1, L-CDR2, L-CDR3, wherein:
(1) L-CDR1 comprises SEQ ID NO: 143;
(2) L-CDR2 comprises SEQ ID NO: 144; and
(3) L-CDR3 comprises SEQ ID NO: 95; and
(b) a variable V H -Region comprising complementary determining regions, H-CDR1, H-CDR2, H-CDR3, wherein:
(1) H-CDR1 comprises SEQ ID NO: 146;
(2) H-CDR2 comprises SEQ ID NOs: 192; and
(3) H-CDR3 comprises SEQ ID NOs: 93.
2. The antibody molecule according to claim 1 , wherein the antibody is of the IgG1 subtype.
3. The antibody molecule according to claim 1 , wherein the variable V H -region comprises SEQ ID NO: 89; and the variable V L -region comprises SEQ ID NO: 91.
4. The antibody molecule according to claim 3 , wherein the antibody is of the IgG1 subtype.
5. The antibody molecule according to claim 1 , wherein the variable V H -region comprises SEQ ID NO: 425; and the variable V L -region comprises SEQ ID NO: 91.
6. The antibody molecule according to claim 5 , wherein the antibody is of the IgG1 subtype.
7. A pharmaceutical composition comprising an antibody molecule according to claim 1 and a pharmaceutically acceptable carrier or diluent.
8. A pharmaceutical composition comprising an antibody molecule according to claim 4 and a pharmaceutically acceptable carrier or diluent.
9. A pharmaceutical composition comprising an antibody molecule according to claim 6 and a pharmaceutically acceptable carrier or diluent.